Supernus Pharmaceuticals, Inc.
Method of treatment of attention deficit/hyperactivity disorder (ADHD)
Last updated:
Abstract:
The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.
Status:
Grant
Type:
Utility
Filling date:
6 Jun 2017
Issue date:
10 May 2022